Clorazepate Dipotassium recalls

Clorazepate Dipotassium products have been recalled 2 times, most recently on 15 May 2024. The recalling company is usually Aurobindo Pharma USA.

Total recalls2since 2024

Last 12 months0reported

Class I00% of total

Ongoing2latest 15 May 2024

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why clorazepate dipotassium is recalled

Other Reasons2100%

Companies

Aurobindo Pharma USA2100%

By year

20242100%

Ongoing clorazepate dipotassium recalls

2 active

Reported	Class	Recall	Company	Reason	Where
15 May 2024Drug	CLASS II	Clorazepate Dipotassium Tablets, USP, 3.75 mg, a) recalledClorazepate Dipotassium	Aurobindo Pharma USA	Other	Nationwide
15 May 2024Drug	CLASS II	Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) recalledClorazepate Dipotassium	Aurobindo Pharma USA	Other	Nationwide

All clorazepate dipotassium recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
15 May 2024Drug	CLASS II	Clorazepate Dipotassium Tablets, USP, 3.75 mg, a) recalledClorazepate Dipotassium	Aurobindo Pharma USA	Other	Nationwide
15 May 2024Drug	CLASS II	Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) recalledClorazepate Dipotassium	Aurobindo Pharma USA	Other	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.